1st Speech and Swallowing in Parkinson’s Disease School

1st Speech and Swallowing in Parkinson’s Disease School
Aix-en Provence, France – August 31-September 2, 2017

Course Description

The 1st Speech and Swallowing in Parkinson’s Disease School takes place in Provence, France, August 31-September 2, 2017. Dysarthria in Parkinson’s disease (PD) is primarily characterized by hypophonia and dysprosody. It worsens during the disease progression with a poor and variable response to pharmacological and/or neurosurgical treatments. Hypophonia in PD usually responds well to intensive speech therapies, but speech therapy is rarely proposed to PD patients.

While speech therapy gained growing relevance in the management of patients with PD, evidence-based evaluation of behavioral speech therapies for PD remains difficult due to the heterogeneity of dysarthria, as well as the variety of available treatments. Speech therapy programs are often individually tailored to each patient for reaching specific objectives, therefore limiting the conclusions of clinical trials. Moreover, the need for specific training of therapists may restrict access to this therapy.

The main objective of the 1st Speech and Swallowing in Parkinson’s Disease School is to provide an opportunity for speech therapists to keep informed about clinical aspects of Parkinsonism, as well as to provide the most recent knowledge about clinical management of dysarthria in PD. During the school, the idea is to provide recommendations while educating students, clinicians and researchers in order to improve their understanding of speech impairment in PD as a multidimensional, multidisciplinary and multiparametric symptom.

The program is designed as a 2.5 days school in order to provide an opportunity for small group workshops. We look forward to an inspiring event, providing a unique opportunity to discuss speech therapy in PD with a transdisciplinary team.

Recommended Audience
  • Speech therapists and speech pathologists
  • Neurologists and ENTs
  • Heath professionals specialized in PD management
  • Speech scientists, neuroscientists
Learning Objectives

Upon conclusion of this course, the participant will be able to:

  • Discuss the neurological bases of normal speech production and speech impairment in PD
  • Precisely assess and describe speech impairment and swallowing impairment in PD
  • Select and design a rehabilitation program targeting speech and/or swallowing impairments in PD patients
  • Implement an evidence-based approach to treatment
  • Explain the difficulty of assessing speech impairment in PD as part of a multidisciplinary approach
  • Consider patient-reported outcome measures as part of the evaluation and follow-up program of management
  • Identify how and when speech therapy can be fully effective according to disease progression and in association with medical and/or surgical treatments
Physician Competencies
  • Patient care and procedural skills
  • Work in interdisciplinary teams
  • Increase medical knowledge
  • Teams and teamwork

Laboratoire Parole et Langage - UMR 7309
CNRS/Aix-Marseille Université, 5 Avenue Pasteur, 13100 Aix-en Provence, France


We use cookies to give you the best possible experience with our website. These cookies are also used to ensure we show you content that is relevant to you. If you continue without changing your settings, you are agreeing to our use of cookies to improve your user experience. You can click the cookie settings link on our website to change your cookie settings at any time. The MDS site uses multiple domains, including mds.movementdisorders.org and mds.execinc.com. This cookie policy only covers the primary movementdisorders.org domain. Please refer to the MDS Privacy Policy for information on how to configure cookies for all other domains on the MDS site.
Cookie PolicyPrivacy Notice